Today: 14 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth shares rose 0.7% to $337.27 after rebounding from a 2% drop Thursday. The move followed UnitedHealthcare’s launch of a six-month pilot to speed Medicare Advantage payments for rural hospitals in four states. Investors are focused on the company’s Jan. 27 earnings and 2026 outlook. Rural providers face financial strains as federal budget changes loom.
15 January 2026
··
Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing shares rose 1.6% to $246.40 by midday Thursday after Bernstein raised its price target to $298. Delta ordered 30 Boeing 787-10 jets, with options for 30 more. Boeing delivered 600 jets in 2025, its highest since 2018, and net orders surpassed Airbus for the first time in seven years. Investors await Boeing’s Jan. 27 earnings for updates on cash flow and 2026 outlook.
15 January 2026
··
Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials surged 7.8% to $325.41 Thursday after TSMC raised its 2026 capital spending outlook to up to $56 billion, far above forecasts. Barclays upgraded Applied to “overweight” and Stifel raised its price target, citing stronger chip equipment demand. U.S. chip tool stocks rallied broadly. Applied warned that tighter U.S. export rules could cut $600 million from 2026 revenue.
15 January 2026
··
Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Eli Lilly shares fell 4.7% to $1,022.50 after Reuters reported the FDA delayed its decision on the company’s experimental weight-loss pill to April 10. Strive Specialties sued Lilly and Novo Nordisk in Texas, alleging anticompetitive practices tied to GLP-1 drugs. Novo Nordisk shares dropped 3.6%. Investors await Lilly’s Feb. 4 earnings for updates on the pill’s timeline and legal risks.
15 January 2026
·
IREN stock slips as broker trims forecasts but keeps $80 target

IREN stock slips as broker trims forecasts but keeps $80 target

IREN shares fell 0.5% to $52.61 Thursday after H.C. Wainwright cut near-term earnings forecasts but kept a Buy rating and $80 target. Bitcoin dropped 0.8%, pressuring crypto-linked stocks. IREN’s AI push includes a $9.7 billion Microsoft deal and a $5.8 billion Dell supply agreement, both tied to GPU data center expansion in Texas. Delays in execution could trigger penalties, according to recent filings.
15 January 2026
·
Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

Salesforce shares fell 1.6% to $235.78 late Thursday morning, underperforming gains in major U.S. stock indexes. Wolfe Research reiterated an Outperform rating and $350 price target after Salesforce’s Agentforce World Tour in Boston. Salesforce is rolling out new AI features in Slack and announced a health care software win with Spain’s Adamed Laboratorios. The stock is still recovering from a 6.5% drop earlier in the week.
15 January 2026
··
1 … 303 304 305 306 307 … 704

Stock Market Today

  • Where to Find Safety in Today's Volatile Stock Market
    March 14, 2026, 5:06 AM EDT. FTSE 100 utilities, such as National Grid, have shown resilience in 2026 amid market volatility due to their stable cash flows and favorable regulation, attracting investor attention. Tech giants like Microsoft have struggled, falling 15% this year amid uncertainty around artificial intelligence's impact on earnings. Short-term market safety is elusive; share prices can swing dramatically. However, long-term investments in robust companies like Rentokil Initial, despite current debt pressures, offer potential upside. Climate change-driven demand for pest control supports Rentokil's outlook. Investors should avoid using capital needed soon for stocks due to market unpredictability, but patient holders may benefit from businesses with solid long-term prospects.
Go toTop